# PACLITAXEL

NDC: 67457-937
Generic name: PACLITAXEL
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20251009

FDA application: ANDA217877

## Active ingredients

- PACLITAXEL: 100 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-937"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-937
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1a06de1-d9a4-460a-b87d-5e40305b065c